CClinicalTrials.gg
CompletedNCT04833868Updated Apr 13, 2021

Effect of Hippotherapy and Schroth Exercise on Pulmonary Function and Aerobic Capacity in Idiopathic Scoliosis

An interventional study of hippotherapy and schroth exercise and schroth exercise in Scoliosis Idiopathic, sponsored by Batterjee Medical College. Completed at 1 site in Saudi Arabia. Open to participants aged 12 Years to 18 Years. Per ClinicalTrials.gov, last updated 2021-04-13.

Sponsored by Batterjee Medical College · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 1 month after the study started (first participant enrolled Feb 2020, registered Mar 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
45
Allocation
Randomized
Ages
12 Years to 18 Years
Sex
All
01

Study summary

BACKGROUND: Idiopathic scoliosis has been identified as a common spinal malalignment that negatively impacts the respiratory system and physical conditioning in adolescents. Hippotherapy is an equestrian intervention that optimizes physical performance and mobility in a bunch of contexts; however, its influence on pulmonary function remains unclear.

AIM: This research aimed to analyze the impact of ten weeks of hippotherapy combined with Schroth exercises on ventilatory function and aerobic capacity in AIS.

DESIGN: Randomized Controlled Trial SETTING: Outpatients attend a single center that includes a rehabilitation room and recreational riding center.

POPULATION: Forty-five patients were arbitrarily recruited to the experimental (N= 22) and control group (N=23).

METHODS: Patients in the experimental group received 30 minutes of walking and sitting trot training, 15 sessions split into 2 phases over ten weeks. The two groups attended a 60-minute session of Schroth's intervention, 3 times/ week for 10 weeks. Two-way ANOVA for between-group comparisons and independent t-test for within-group comparisons were used in the statistical analysis.

Read the detailed description

A total of 45 patients (13 males and 32 females) participated in the current study. The participants were assigned to one of two groups in a random manner: an experimental group who received hippotherapy combined with Schroth Exercise and the control group who received only schorth exercise. (FVC, FEV1, FEV1/FVC, MVV, and 6MWT) were measured before and after 10 weeks intervention

02

Conditions studied

  • Scoliosis Idiopathic

Browse trials for

Keywords

  • Hippotherapy
  • Pulmonary Function
  • Idiopathic Scoliosis
03

In context

Scoliosis

594 studies on the registry are indexed under Scoliosis; 139 are open to participants now.

This study's enrollment of 45 is close to the median of 44 across 344 interventional studies indexed under Scoliosis.

Browse Scoliosis studies →

Lead sponsor

Batterjee Medical College is the lead sponsor of 16 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • all types of curves,
  • curves between 10 and 20 degrees (29),
  • Risser grade 0 to 5
  • the availability to be engaged in once a week visit

Exclusion criteria

Exclusion Criteria:

Adolescents with:

  • obstructive pulmonary diseases
  • associated neuromuscular diseases
  • recent infectious episodes in the previous two months
  • history of cardiovascular or psychological disorders
  • any significant history of riding horses
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
45 participants (actual)

Study arms

  • Experimental
    hippotherapy combined with Schroth Exercise

    received hippotherapy combined with Schroth Exercise hippotherapy session for 30 minutes of walking and sitting trot training, 15 sessions split into 2 phases over ten weeks in addition to 60-minute session Schroth's intervention, 3 times/ week for 10 weeks

    Other: hippotherapy and schroth exercise

  • Active comparator
    Schroth Exercise

    received Schroth's intervention for a 60-minute session, 3 times/ week for 10 weeks

    Other: schroth exercise

Interventions

  • Otherhippotherapy and schroth exercise

    pulmonary function and aerobic capacity were measured in patients with mild idiopathic scoliosis before and after 10-week hippotherapy intervention combined with Schroth exercise

  • Otherschroth exercise

    pulmonary function and aerobic capacity were measured in patients with mild idiopathic scoliosis before and after 10-week of Schroth exercise

06

What researchers measure

Primary outcomes

  1. FVC in liters

    change in FVC measured Using Spiromaster PC-10 Spirometer

    Time frame: ten weeks

  2. FEV1 in liters

    change in FEV1 measured Using Spiromaster PC-10 Spirometer

    Time frame: ten weeks

  3. MVV in liters/min

    change in MVV measured Using Spiromaster PC-10 Spirometer

    Time frame: ten weeks

  4. FEV1/FVC in percentage

    change in FEV1/FVC measured Using Spiromaster PC-10 Spirometer

    Time frame: ten weeks

  5. aerobic capacity

    6MWT

    Time frame: ten weeks

07

Study locations

1 site
  • Battarjee Medical College
    Jeddah, Saudi Arabia
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 13, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04833868
Lead sponsor
Batterjee Medical College
Collaborators
Taif University
Responsible party
Mohamed A. Abdel Ghafar (associate Professor, Batterjee Medical College) — Principal investigator
First posted
Apr 6, 2021
Start date
Feb 20, 2020
Primary completion
Dec 18, 2020
Completion
Mar 7, 2021
Last update
Apr 13, 2021

Study contacts

Mohamed M. Abdel Ghafar, Ph.D
principal investigator · Batterjee Medical College

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion